CIK 0001374328 · Non-accelerated filer<br>Smaller reporting company
FITLIFE BRANDS, INC.
Sign in to watch- Ticker
- FTLF
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- Phone
- 402-884-1894
- Business address
- 5214 S. 136TH STREET, OMAHA, NE, 68137
- Former names
- BOND LABORATORIES, INC.
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,500 shares at an average $0.41 ($8,355)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 45,939 shares at $0.47 ($21,761)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 9,500 shares at $0.46 ($4,323)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $0.50 ($2,500)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,500 shares at $0.50 ($2,750)
- 4 Open-market buy Chief Executive Officer bought 45,895 shares at an average $0.48 ($21,921)
- 4 Open-market buy Chief Executive Officer bought 33,600 shares at an average $0.50 ($16,720)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $0.43 ($1,063)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 17,168 shares at an average $0.42 ($7,186)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 17,168 shares at an average $0.42 ($7,186)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 12,377 shares at $0.40 ($4,951)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 12,377 shares at $0.40 ($4,951)
- 4 Grant or award Director acquired 9,147 shares (grant or award)
- 4 Grant or award Director acquired 13,720 shares (grant or award)
- 4 Grant or award Director acquired 13,720 shares (grant or award)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $0.41 ($4,100)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 6,700 shares at $0.42 ($2,814)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 11,991 shares at an average $0.34 ($4,079)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $0.30 ($1,501)
Page 4 of 9 · 175 filings